Company profile: Vemedia
1.1 - Company Overview
Company description
- Provider of owned, branded OTC consumer healthcare pharmaceuticals, developing, producing and selling self-medication products. Portfolio includes Valdispert for stress, insomnia, mood and concentration issues using natural ingredients; Excilor for fungal nail, warts, skin tags and athlete's foot; Oenobiol for beauty through nutrition (skin, sun, weight, hair); and ROTER for resistance, cystitis, pain, fever, cough, throat, airways and joint care.
Products and services
- Excilor: OTC-branded products that treat fungal nail infections, warts, skin tags, athlete’s foot and protect against foot infections, available in over 20 countries
- Oenobiol: Science-based nutrition products for beauty through nutrition, addressing skin care, sun exposure, weight control, and hair health
- ROTER: OTC-branded self-medication products for health support, including resistance, cystitis, pain, fever, cough, throat, airways, and joint care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vemedia
UCAN
HQ: United States
Website
- Description: Provider of energy, hydration, and protein products that deliver steadily over time, with no sugar or caffeine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UCAN company profile →
Func Food
HQ: Finland
Website
- Description: Provider of sports nutrition products, developed and manufactured by Func Food Finland Oy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Func Food company profile →
OptiBiotix
HQ: United Kingdom
Website
- Description: Provider of microbiome-modulating strains, compounds, and formulations used as food ingredients and supplements to prevent and manage disease. Products include SlimBiome for hunger-free weight management, LPLDL (Lactobacillus plantarum) to lower cholesterol and blood pressure, CholBiome supplements using LPLDL, and OptiBiome, OptiScreen, and OptiBiotic platforms for screening and developing microbiome modulators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OptiBiotix company profile →
Nutraceutix
HQ: United States
Website
- Description: Provider of specialty pharmaceutical and probiotic solutions, developing and commercializing prescription, over-the-counter, and nutritional products using controlled delivery technology. Develops water-soluble/insoluble and high/low-dose drugs in analgesic, cardiovascular, diabetes, anti-nausea, and pulmonary areas, with two US production sites and a global partner network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutraceutix company profile →
USANA
HQ: United States
Website
- Description: Provider of nutritional products and supplements to support overall health, including vitamins, minerals, and antioxidants; offerings include CellSentials and the HealthPak 28-day supply, plus proprietary InCelligence formulation and Hybrid bilayer tablet technologies, and the Olivol Botanical Blend.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full USANA company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vemedia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vemedia
2.2 - Growth funds investing in similar companies to Vemedia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vemedia
4.2 - Public trading comparable groups for Vemedia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →